Argireline vs SNAP-8: Telling Two Related Peptides Apart

If you are comparing Argireline vs SNAP-8 on a supplier sheet, the chemistry is simpler than the naming. Argireline is the trade name for acetyl hexapeptide-8, SNAP-8 is the trade name for acetyl octapeptide-3, and the second is the first with two extra residues bolted onto the C-terminal end. Everything a QC lab needs to separate them follows from that: one clear mass gap, a shared methionine that oxidises, and a polarity that makes both awkward on a standard reversed-phase column. This article walks through each, with the receiving checks that matter when a lab buys either one in volume.

Argireline vs SNAP-8 at the sequence level

Write the two sequences one above the other and the relationship is obvious:

• Acetyl hexapeptide-8 (Argireline): Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2
• Acetyl octapeptide-3 (SNAP-8): Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2

The first six residues are identical. The octapeptide adds alanine and aspartic acid before the C-terminal amide. Both sequences were modelled on the N-terminal region of SNAP-25, one of the proteins that make up the SNARE complex, and in the in-vitro literature both are studied as short mimics of that region that compete with SNARE assembly. For analytical purposes the biology is background. What matters is that one is a strict extension of the other.

The numbers a certificate should carry

The difference between the two monoisotopic masses is 186.06 Da. That figure is the combined residue mass of alanine (71.04) and aspartic acid (115.03), which is a useful sanity check. If a spectrum of one product also shows the other mass, you are looking at a mixture or a cross-labelled vial, not a synthesis by-product.

Check the formula field, not only the mass. Copied or templated certificates sometimes carry a formula that does not add up to the stated molecular weight, and a mismatch between the two is a quick sign the document was not generated for the material it describes.

End groups are part of the identity

Neither compound has a free N-terminus or a free C-terminal acid. The acetyl cap and the amide are both built in, and each has a characteristic failure mode:

• Missing acetyl: the peptide comes out 42 Da lighter. This is what an incomplete capping step produces.
• Free acid instead of amide: the peptide comes out about 1 Da heavier. It is easy to miss on a low-resolution instrument and may co-elute with the parent.

A specification that gives only the one-letter sequence, with no Ac- prefix or -NH2 suffix, describes a different molecule. When writing a purchase specification, spell out both terminal states.

Methionine: the impurity you should expect

Both peptides carry methionine at position 3. Methionine picks up an oxygen to form the sulfoxide under ordinary conditions, in solution and, given moisture and air, in the dry solid too. The result is a species 16 Da heavier that elutes ahead of the main peak because it is more polar. Further oxidation to the sulfone adds another 16 Da, though it is much less common.

A small sulfoxide peak on either chromatogram is normal. The questions that matter for a multi-vial order are how large it is on the certificate and whether it grows between receipt and use. If a vial opened six months after delivery shows noticeably more oxidation than the certificate did, look at the storage log and the seal before questioning the synthesis.

Why both are hard to hold on a C18 column

These are small, highly charged peptides with very little hydrophobic surface. The hexapeptide has two glutamates and two arginines; the octapeptide adds an aspartate. At the low pH of a typical TFA gradient, both arginine side chains carry a positive charge while the carboxyl groups stay mostly uncharged, which leaves a polar, positively charged molecule that barely interacts with a conventional bonded phase.

In practice that means early elution, sometimes close to the void volume, where salts and small polar impurities also appear. Methods that handle these peptides well usually begin the gradient with almost no acetonitrile, run on a column that tolerates fully aqueous conditions and rely on an ion-pairing agent to build retention. When you read a certificate, check that the main peak is well clear of the solvent front. A purity figure taken from a peak sitting in the void tells you very little.

Detection at 214 nm only

With no aromatic residue anywhere in either chain, a 280 nm trace is essentially blank. Detection has to be at 214 nm, where the peptide bond absorbs, and that wavelength is more sensitive to mobile-phase quality and baseline drift. The sulfur in methionine does not help here. If a lab wants an orthogonal confirmation, mass detection provides it; a second UV wavelength does not.

Names that change, and the fields that don’t

Few research peptides carry as many aliases as this pair. The hexapeptide has appeared as acetyl hexapeptide-3, acetyl hexapeptide-8 and simply hexapeptide-8. The octapeptide has appeared as acetyl octapeptide-1 and acetyl octapeptide-3. These numbers come from cosmetic ingredient naming conventions, which have been revised over time, not from any chemical rule, so two different numbers can point to the same molecule.

The sequence with its end groups and the calculated mass do not change with the naming convention. Put those on the order and on your inventory record, and the trade name becomes a convenience rather than a source of error.

A receiving check for either compound

1. Confirm the label and certificate name the same compound and show the same mass: about 889.0 Da average for the hexapeptide, about 1075.2 Da for the octapeptide.
2. Check that Ac- and -NH2 appear in the stated sequence.
3. Note the reported sulfoxide level so later analyses have a baseline.
4. Confirm the chromatogram’s main peak is retained well away from the void.
5. Log each vial against its lot, then store sealed, cold, dry and dark to slow oxidation.

Bulk Peptides does not currently stock either of these compounds. The checks above apply wherever the material is sourced, and they carry over to any short, polar, methionine-containing peptide.

Written as a reference for analytical and procurement staff. Both compounds are discussed here solely as laboratory research materials; nothing in this article concerns use in or on people or animals.